[ DayTwo raises $12M in Series A ]
DayTwo has raised $12 million in Series A funding.
Founded 2015, Daytwo provides actionable health solutions based on gut microbiome, utilizing the DayTwo Microbiome Platform™. Its first product, the DayTwo Personalized Nutrition Platform, is based on groundbreaking research from the Weizmann Institute of Science led by Prof. Eran Segal and Dr. Eran Elinav (Cell, Nov15). The research showed that food that is healthy for one person may not be healthy for another, thus nutrition that lowers post meal sugar responses must be personally tailored.
The company also announces a collaboration with the Janssen Human Microbiome Institute to further develop its microbiome science based health solutions.
|Founder / CEO||Lihi Segal|
|Investors||Johnson & Johnson|